Melevodopa
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Melevodopa is a dopaminergic agent. It is the methyl ester of levodopa. It is used in tablet form as an effervescent prodrug with 250 times higher water solubility compared to tablet levodopa.[1]
See also
References
- ↑ Patrick Hickey and Mark Stacy (2011). “Available and emerging treatments for Parkinson’s disease”. Drug Des Devel Ther. 5: 241–254. doi:10.2147/DDDT.S11836. PMC 3096539. PMID 21607020.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH